`

Corcept Therapeutics

Biotechnology Research

Last Updated: November 20, 2025
Revenue
$615.03M
funding-icon Total Funding
$0.53M
Size
201 - 500

Frequently Asked Questions About Corcept Therapeutics

What does Corcept therapeutics do?+

At the center of discovery and development of cortisol modulation. Our mission is to unlock the potential of cortisol and revolutionize the treatment of serious diseases. For the last 25 years, weve led the way in the research and development of selective glucocorticoid receptors (GR) antagonists, molecules that alter GR and regulate cortisol levels. In 2012, we received FDA approval of a groundbreaking cortisol receptor blocker and the first approved treatment for hypercortisolism (Cushings syndrome). Today, global partnerships and collaborations form the bedrock of our robust development programs, including more than 500 GR antagonists for conditions spanning oncology, endocrine, and...

What is Corcept therapeutics's industry? +

Corcept therapeutics operates in the Biotechnology research industry.

What is Corcept therapeutics's revenue? +

Corcept therapeutics's revenue is $615.03m

What is Corcept therapeutics's company size? +

Corcept therapeutics has 201 - 500 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.